Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification - Join Clinical Trial NCTNCT05259605
How to Join This Clinical Trial - NCTNCT05259605
Learn how to participate in this clinical trial studying an investigational therapy for Glioma, Glioneuronal Tumor, Choroid Plexus Tumor, Pineal Tumors, Germ Cell Tumor, Tumor of the Sellar Region, Diffuse Midline Glioma, H3 K27M-Mutant, Ependymoma, Embryonal Tumor, Pineal Tumor, Hemangiopericytoma, Hemangioblastoma, Melanocytic Tumor of CNS. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Glioma, Glioneuronal Tumor, Choroid Plexus Tumor, Pineal Tumors, Germ Cell Tumor, Tumor of the Sellar Region, Diffuse Midline Glioma, H3 K27M-Mutant, Ependymoma, Embryonal Tumor, Pineal Tumor, Hemangiopericytoma, Hemangioblastoma, Melanocytic Tumor of CNS. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Glioma, Glioneuronal Tumor, Choroid Plexus Tumor, Pineal Tumors, Germ Cell Tumor, Tumor of the Sellar Region, Diffuse Midline Glioma, H3 K27M-Mutant, Ependymoma, Embryonal Tumor, Pineal Tumor, Hemangiopericytoma, Hemangioblastoma, Melanocytic Tumor of CNS
- Treatment Being Tested
- Investigational treatment
- Study Phase
- Clinical trial phase - Research study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05259605 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 41 locations. Find a study site near you:
Clinical Research Site
Innsbruck, - Austria
Status: RECRUITING
Clinical Research Site
Vienna, - Austria
Status: RECRUITING
Clinical Research Site
Aalst, - Belgium
Status: RECRUITING
Clinical Research Site
Anderlecht, - Belgium
Status: RECRUITING
Clinical Research Site
Brussels, - Belgium
Status: RECRUITING
Clinical Research Site
Liège, - Belgium
Status: RECRUITING
Clinical Research Site
Roeselare, - Belgium
Status: RECRUITING
Clinical Research Site
Lyon, - France
Status: RECRUITING
Clinical Research Site
Marseille, - France
Status: RECRUITING
Clinical Research Site
Paris, - France
Status: RECRUITING
And 31 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this clinical trial for Glioma, Glioneuronal Tumor, Choroid Plexus Tumor, Pineal Tumors, Germ Cell Tumor, Tumor of the Sellar Region, Diffuse Midline Glioma, H3 K27M-Mutant, Ependymoma, Embryonal Tumor, Pineal Tumor, Hemangiopericytoma, Hemangioblastoma, Melanocytic Tumor of CNS:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai as Your Clinical Trial Matching Service
Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:
- Find clinical trials that match your condition
- Get matched to the right study location near you
- Connect directly with study coordinators
- Understand if you qualify with simplified eligibility screening
- Navigate the enrollment process with personalized support
- Access new treatments through clinical research participation